Clinical Trials Map
The results of clinical trials suggest that psychedelics could be used for a range of therapeutic purposes, but figuring out how to participate in psychedelic-assisted therapy as either a therapist or a patient can be complicated. BCSP’s clinical trials map, featuring data from ClinicalTrials.gov, provides a way to navigate past, ongoing and future trials.
Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
Ohio State University Department of Psychiatry and Behavioral Health at the Davis Medical Research CenterColumbus, Ohio, United States
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
UAB Psychiatry and Behavioral NeurologyBirmingham, Alabama, United States
Lighthouse PsychiatryGilbert, Arizona, United States
Pillar Clinical Research – Little RockLittle Rock, Arkansas, United States
Behavioral Research Specialists, LLCGlendale, California, United States
Sun Valley Research CenterImperial, California, United States
CalNeuro Research GroupLos Angeles, California, United States
ATP Clinical ResearchOrange, California, United States
NRC Research InstituteOrange, California, United States
Inland Psychiatric Medical Group Inc (IPMG Research)San Juan Capistrano, California, United States
Psychedelic Science InstituteSanta Monica, California, United States
Stanford UniversityStanford, California, United States
Yale School of Medicine – Yale Program for Psychedelic ScienceNew Haven, Connecticut, United States
CNS HealthcareJacksonville, Florida, United States
Accel Research Sites – MaitlandMaitland, Florida, United States
Aqualane Clinical ResearchNaples, Florida, United States
Emory University Dept of Psychiatry and Behavioral StudiesAtlanta, Georgia, United States
Psych AtlantaMarietta, Georgia, United States
Rush UniversityChicago, Illinois, United States
Tandem Clinical ResearchMarrero, Louisiana, United States
Johns Hopkins MedicineBaltimore, Maryland, United States
Institute for Integrative TherapiesEden Prairie, Minnesota, United States
Bio Behavioral HealthToms River, New Jersey, United States
New York State Psychiatric InstituteNew York, New York, United States
SP Research PLLCOklahoma City, Oklahoma, United States
Adams Clinical PhiladelphiaPhiladelphia, Pennsylvania, United States
Flourish Research PhiladelphiaPhiladelphia, Pennsylvania, United States
Austin Clinical Trial PartnersAustin, Texas, United States
North Texas Clinical TrialsFort Worth, Texas, United States
Brain Health Consultants and TMS CenterHouston, Texas, United States
Clinical Trials of Texas, LLCSan Antonio, Texas, United States
Core Clinical ResearchEverett, Washington, United States
Seattle Neuropsychiatric Treatment CenterSeattle, Washington, United States
Royal Prince Alfred HospitalCamperdown, New South Wales, Australia
Thompson Brain & Mind Healthcare (TBMH)Maroochydore, Queensland, Australia
Ramsay ClinicMelbourne, Victoria, Australia
Neurocentrix ResearchMelbourne, Victoria, Australia
Monash University – Notting HillNotting Hill, Victoria, Australia
Institute of neuropsychiatric Care (INEP)Prague, Czechia
Psyon s.r.o.Prague, Czechia
A-SHINE s.r.o.Předměstí, Czechia
Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des SaarlandesHomburg, Saarland, Germany
Charité Universitaetsmedizin BerlinBerlin, Germany
University Hospital FrankfurtFrankfurt am Main, Germany
Central Institute of Mental HealthMannheim, Germany
Eginitio HospitalAthens, Greece
Attikon University HospitalAthens, Greece
Papageorgiou General HospitalThessaloniki, Greece
Sheaf House – Tallaght Adult Mental Health ServiceDublin, Ireland
La Nua Day Hospital Mental Health CentreGalway, Ireland
Uniwersytecki Szpital Kliniczny W BiałymstokuBialystok, Poland
Promente – Centrum Neurologii i Psychogeriatrii w BydgoszczyBydgoszcz, Poland
UCKGdansk, Poland
Centrum Badan Klinicznych PI-House Sp. z o.oGdansk, Poland
MTZ Clinical Research Powered by PratiaWarsaw, Poland
Department of Pharmacology and Physiology of CNSWarsaw, Poland
Cambridge University Hospital NHSCambridge, United Kingdom
Clerkenwell Health – DoncasterDoncaster, United Kingdom
NHS Research ScotlandEdinburgh, United Kingdom
Queen Elizabeth University HospitalGlasgow, United Kingdom
St Pancras Clinical ResearchLondon, United Kingdom
King's College LondonLondon, United Kingdom
Clerkenwell Health – Welbeck StreetLondon, United Kingdom
Re:Cognition HealthLondon, United Kingdom
Clerkenwell Health – Baker StreetLondon, United Kingdom
Wolfson Unit – Cumbria, Northumberland, Tyne and Wear NHS Foundation TrustNewcastle upon Tyne, United Kingdom
Ascend Clinical ResearchReading, United Kingdom
Sheffield Health and Social Care NHS Foundation TrustSheffield, United Kingdom
Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD
University Hospital BaselBasel, Switzerland
Psilocybin Microdosing on Cognition, Mood and Quality of Life
Olin Neuropsychiatry Research CenterHartford, Connecticut, United States
Mindfulness-based Psilocybin Therapy for PTSD
Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants
University Hospital BaselBasel, Canton of Basel-City, Switzerland
Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial
Maastricht UniversityMaastricht, Netherlands
University Hospital BaselBasel, Switzerland
Investigation of Psychedelic Effects in Psychoactive Substances
Johns Hopkins Center for Psychedelic and Consciousness ResearchBaltimore, Maryland, United States
Effects of Repeated Psilocybin Dosing in OCD
Enact Research Collaborative (40 Temple St, 4th Floor)New Haven, Connecticut, United States
Yale Program for Psychedelic ResearchNew Haven, Connecticut, United States
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
Johns HopkinsBaltimore, Maryland, United States
Page 1 of 16
How to use the clinical trials map
Clinical trials have provided growing evidence that ketamine, psilocybin, and MDMA can work in combination with therapy to help alleviate a range of mental disorders, including PTSD, depression, substance-use disorders, and anxiety. The field is advancing rapidly, but it can be difficult to navigate changing information to learn more about specific trials.
In the map view, explore clinical trials based on location. Click on a pink cluster or use the + button to zoom in on a particular location. Click on a smaller pink dot to access an overview of a particular clinical trial, including the substance, the phase, and relevant conditions. Click on the “Full Trial Record” link to learn more about the trial on the ClinicalTrials.gov site.
In the list view, the clinical trials tracker offers a tool for researchers and clinicians to quantify and explore trials based on a number of factors. Click on “Filter” to see relevant trials based on substance, trial status, study phase and more. Where the list shows closed trials users are able explore published results, including searching by institution.